Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Search Results for "avir":
Results: 51
Quotes
Show all (2)
News
Israeli private eye accused of hacking was questioned about DC public affairs firm, sources say
By Reuters
By Raphael Satter and Christopher Bing WASHINGTON - An Israeli private investigator sought by the United States over hack-for-hire allegations previously told colleagues that he had been questioned...
Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024
By Investing.com
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial
By Investing.com
Atea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral diseases, has announced notable advancements in its clinical trials and a robust financial position in...
Analysis
Basilea Pharmaceutica: Hat Trick
By Edison
Basilea Pharmaceutica AG (SIX:BSLN) announced a hat trick of positive news flow in June. This includes two separate licensing deals covering Cresemba (for invasive mould infections) and Zevtera, as...
Lilly's (LLY) Tyvyt BLA Accepted for Review by FDA for NSCLC (Revised)
By Zacks Investment Research
Eli Lilly and Company (NYSE:LLY) LLY announced that the FDA has accepted for review its biologics license application (BLA) seeking approval for sintilimab injection for the first-line treatment of...
Repligen (RGEN) Beats on Q1 Earnings & Sales, Raises 2021 View
By Zacks Investment Research
Repligen (NASDAQ:RGEN) Corporation RGEN delivered first-quarter 2021 adjusted earnings per share of 68 cents, beating the Zacks Consensus Estimate of 43 cents. The bottom line also came in higher than...
Results: 2
Refine Results
Instrument Type
Region
Sector
Industry
- All Industries
- Coal
- Oil & Gas
- Oil & Gas Related Equipment and Services
- Renewable Energy
- Uranium
- Chemicals
- Metals & Mining
- Construction Materials
- Paper & Forest Products
- Containers & Packaging
- Aerospace & Defense
- Machinery, Tools, Heavy Vehicles, Trains & Ships
- Construction & Engineering
- Diversified Industrial Goods Wholesale
- Professional & Commercial Services
- Freight & Logistics Services
- Passenger Transportation Services
- Transport Infrastructure
- Automobiles & Auto Parts
- Textiles & Apparel
- Homebuilding & Construction Supplies
- Household Goods
- Leisure Products
- Hotels & Entertainment Services
- Media & Publishing
- Diversified Retail
- Specialty Retailers
- Beverages
- Food & Tobacco
- Personal & Household Products & Services
- Food & Drug Retailing
- Consumer Goods Conglomerates
- Banking Services
- Investment Banking & Investment Services
- Insurance
- Collective Investments
- Investment Holding Companies
- Healthcare Equipment & Supplies
- Healthcare Providers & Services
- Pharmaceuticals
- Biotechnology & Medical Research
- Semiconductors & Semiconductor Equipment
- Communications & Networking
- Electronic Equipment & Parts
- Office Equipment
- Computers, Phones & Household Electronics
- Integrated Hardware & Software
- Software & IT Services
- Financial Technology (Fintech) & Infrastructure
- Telecommunications Services
- Electrical Utilities & IPPs
- Natural Gas Utilities
- Water & Related Utilities
- Multiline Utilities
- Real Estate Operations
- Residential & Commercial REITs
- Institutions, Associations & Organizations
- Government Activity
- Miscellaneous Educational Service Providers
- School, College & University
- Professional & Business Education
Quotes
Results: 43
Refine Results
Date
Date
Category
Provider
- All Providers
- Reuters
- Investing.com DNA 3rd party news
- Investing.com
- International Business Times
- Yahoo Finance
- FinanceMagnates
- Financial Times
- Forbes
- Bloomberg_video
- Business Insider
- Seeking Alpha
- Financial news 24
- Bloomberg
- DC Forecasts
- Cryptovest
- Cointelegraph
- AMBCrypto
- CoinDesk
- Crypto Globe
- blokt
- test
- The Conversation
- Allrates
- Money Show
- Euronews
- RealVision
- bizportal
- FX Street
- FX Empire
- Investing.com
- Investing.com
- Investing.com
- Crunchbase
- CoinEdition
- DailyCoin
- StockNews
- U.Today
- Investing.com
- Crypto.news
- Investing.com
- Quiver Quantitative
- Stock Story
- Chainwire
News
Please try another search
Results: 0
Tools & Sections
Results: 0
Authors
- Sign up for FREE and get:
- Real-Time Alerts
- Advanced Portfolio Features
- Personalized Charts
- Fully-Synced App